Society for Maternal-Fetal Medicine Special Statement: A quality metric for evaluating timely treatment of severe hypertension

Severe hypertension in pregnancy is a medical emergency. Although expeditious treatment within 30 to 60 minutes is recommended to reduce the risk of maternal death or severe morbidity, treatment is often delayed by >1 hour. In this statement, we propose a quality metric that facilities can use to...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2022-02, Vol.226 (2), p.B2-B9
Main Authors: Combs, C. Andrew, Allbert, John R., Hameed, Afshan B., Main, Elliott K., Taylor, Isabel, Allen, Christie
Format: Article
Language:English
Subjects:
Antihypertensive Agents - therapeutic use
antihypertensive treatment
chronic hypertension
Female
gestational hypertension
Humans
hydralazine
Hypertension, Pregnancy-Induced - diagnosis
Hypertension, Pregnancy-Induced - drug therapy
labetalol
nifedipine
Patient Safety
preeclampsia
Pregnancy
superimposed preeclampsia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Severe hypertension in pregnancy is a medical emergency. Although expeditious treatment within 30 to 60 minutes is recommended to reduce the risk of maternal death or severe morbidity, treatment is often delayed by >1 hour. In this statement, we propose a quality metric that facilities can use to track their rates of timely treatment of severe hypertension. We encourage facilities to adopt this metric so that future reports from different facilities will be based on a uniform definition of timely treatment.
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2021.10.007